|
ALG9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.793200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.632800E-01 |
| Normal-vs-Stage2 |
7.500800E-01 |
| Normal-vs-Stage3 |
5.512000E-02 |
| Normal-vs-Stage4 |
1.436950E-01 |
| Stage1-vs-Stage2 |
3.141400E-01 |
| Stage1-vs-Stage3 |
8.443600E-04 |
| Stage1-vs-Stage4 |
1.120160E-02 |
| Stage2-vs-Stage3 |
1.858220E-01 |
| Stage2-vs-Stage4 |
3.449000E-01 |
| Stage3-vs-Stage4 |
8.202200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.875200E-01 |
| Normal-vs-AfricanAmerican |
5.962400E-02 |
| Normal-vs-Asian |
2.908000E-01 |
| Caucasian-vs-AfricanAmerican |
7.402000E-02 |
| Caucasian-vs-Asian |
3.041600E-01 |
| AfricanAmerican-vs-Asian |
8.690200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.052400E-01 |
| Normal-vs-Female |
4.877400E-01 |
| Male-vs-Female |
1.069550E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.889000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.371200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.135400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.541800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.044000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.359800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.959000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.952800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.135400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.295400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.709000E-01 |
| Normal-vs-Grade 2 |
2.816000E-01 |
| Normal-vs-Grade 3 |
1.480420E-01 |
| Normal-vs-Grade 4 |
2.423900E-02 |
| Grade 1-vs-Grade 2 |
7.425600E-01 |
| Grade 1-vs-Grade 3 |
1.571030E-01 |
| Grade 1-vs-Grade 4 |
5.038300E-02 |
| Grade 2-vs-Grade 3 |
1.916690E-03 |
| Grade 2-vs-Grade 4 |
4.590700E-04 |
| Grade 3-vs-Grade 4 |
2.140200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.355410E-01 |
| Normal-vs-ccB subtype |
3.462600E-01 |
| ccA subtype-vs-ccB subtype |
1.856400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.398000E-01 |
| Normal-vs-N1 |
4.070000E-01 |
| N0-vs-N1 |
4.920000E-01 |
|
|
